These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9786216)

  • 1. Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice.
    Bensadoun JC; Mirochnitchenko O; Inouye M; Aebischer P; Zurn AD
    Eur J Neurosci; 1998 Oct; 10(10):3231-6. PubMed ID: 9786216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice.
    Asanuma M; Hirata H; Cadet JL
    Neuroscience; 1998 Aug; 85(3):907-17. PubMed ID: 9639283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [WITHDRAWN] Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype.
    Thiruchelvam M; Prokopenko O; Cory-Slechta DA; Richfield EK; Buckley B; Mirochnitchenko O
    J Biol Chem; 2005 Jun; 280(23):22530-9. PubMed ID: 15824117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
    Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of adenosine in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences.
    Zafar KS; Siddiqui A; Sayeed I; Ahmad M; Saleem S; Islam F
    J Chem Neuroanat; 2003 Oct; 26(2):143-51. PubMed ID: 14599664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
    Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
    Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease.
    Ridet JL; Bensadoun JC; Déglon N; Aebischer P; Zurn AD
    Neurobiol Dis; 2006 Jan; 21(1):29-34. PubMed ID: 16023352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine.
    Barkats M; Millecamps S; Bilang-Bleuel A; Mallet J
    J Neurochem; 2002 Jul; 82(1):101-9. PubMed ID: 12091470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum.
    Kabuto H; Tada M; Kohno M
    Biol Pharm Bull; 2007 Mar; 30(3):423-7. PubMed ID: 17329831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential resistance of dopaminergic neurons to the toxicity of glutathione depletion is independent of cellular glutathione peroxidase and is mediated by tetrahydrobiopterin.
    Nakamura K; Wright DA; Wiatr T; Kowlessur D; Milstien S; Lei XG; Kang UJ
    J Neurochem; 2000 Jun; 74(6):2305-14. PubMed ID: 10820190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.
    Zhang J; Graham DG; Montine TJ; Ho YS
    J Neuropathol Exp Neurol; 2000 Jan; 59(1):53-61. PubMed ID: 10744035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical changes of nigrostriatal tyrosine hydroxylase and dopamine transporter in the golden hamster after a single intrastriatal injection of 6-hydroxydopamine.
    Rodríguez S; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2013 May; 65(4):463-8. PubMed ID: 22357095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity.
    Offen D; Beart PM; Cheung NS; Pascoe CJ; Hochman A; Gorodin S; Melamed E; Bernard R; Bernard O
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5789-94. PubMed ID: 9576963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonic hedgehog delivered by an adeno-associated virus protects dopaminergic neurones against 6-OHDA toxicity in the rat.
    Dass B; Iravani MM; Huang C; Barsoum J; Engber TM; Galdes A; Jenner P
    J Neural Transm (Vienna); 2005 Jun; 112(6):763-78. PubMed ID: 15586304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.
    Bensadoun JC; Déglon N; Tseng JL; Ridet JL; Zurn AD; Aebischer P
    Exp Neurol; 2000 Jul; 164(1):15-24. PubMed ID: 10877911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of pergolide on dopamine levels in the 6-hydroxydopamine-lesioned mouse brain.
    Asanuma M; Ogawa N; Nishibayashi S; Kawai M; Kondo Y; Iwata E
    Arch Int Pharmacodyn Ther; 1995; 329(2):221-30. PubMed ID: 8540762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
    Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
    J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.